Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Total Debt (2016 - 2023)

vTv Therapeutics (VTVT) has disclosed Total Debt for 10 consecutive years, with $922000.0 as the latest value for Q1 2023.

  • Quarterly Total Debt rose 19.74% to $922000.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $922000.0 through Mar 2023, up 19.74% year-over-year, with the annual reading at $684000.0 for FY2022, 45.8% down from the prior year.
  • Total Debt hit $922000.0 in Q1 2023 for vTv Therapeutics, up from $684000.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $4.5 million in Q1 2021 to a low of $684000.0 in Q4 2022.
  • Historically, Total Debt has averaged $2.1 million across 5 years, with a median of $2.2 million in 2019.
  • Biggest YoY gain for Total Debt was 987.06% in 2019; the steepest drop was 88.43% in 2019.
  • Year by year, Total Debt stood at $2.6 million in 2019, then increased by 10.38% to $2.9 million in 2020, then crashed by 56.04% to $1.3 million in 2021, then plummeted by 45.8% to $684000.0 in 2022, then soared by 34.8% to $922000.0 in 2023.
  • Business Quant data shows Total Debt for VTVT at $922000.0 in Q1 2023, $684000.0 in Q4 2022, and $1.4 million in Q3 2022.